Sunday, September 30, 2018

Mankind Pharma eyes $1 billion topline by FY21

Mankind Pharma eyes $1 billion topline by FY21 The company is also looking at increasing its exports substantially to $100-150 million in the next three years from the present $10 million.

from Moneycontrol Business News https://ift.tt/2Qla994

No comments:

Post a Comment

S&P 500, Nasdaq end higher on Amazon-OpenAI deal; Fed path forward grows murky

Artificial intelligence deals propelled the S&P 500 and Nasdaq higher on Monday, with Amazon's $38 billion agreement with OpenAI and...